Thursday, November 6, 2025

Tech SPAC Aura FAT Projects Acquisition Prices US$100 Million IPO

Special purpose acquisition company Aura FAT Projects Acquisition Corp. (Nasdaq: AFARU) started trading its securities on the Nasdaq Global Market on Wednesday. The firm priced its initial public offering, aiming to raise total proceeds of US$100.0 million.

The offering will entail selling 10.0 million units priced at US$10.00 per unit. Each unit is composed of one Class A common share and one redeemable warrant, each exercisable to purchase one common share at US$11.50 per share.

The company units trade on the Nasdaq big board under the symbol “AFARU”. Once the securities separate, the company shares and warrants will trade under the ticker symbols “AFAR” and “AFARW”, respectively.

The proposed offering is being managed by EF Hutton as the sole bookrunner. The underwriters were granted a 45-day over-allotment option to purchase additional 1.5 million company units.

The offering is expected to close on April 18, 2022, subject to customary closing conditions.

The Singapore-based blank check company intends to focus its search on “emerging technology companies” in Southeast Asia and Australasia. Tech sectors being considered include Web 3.0, blockchain, cryptocurrency, digital ledger, e-gaming, among others.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

PMET Resources: Lithium Feasibility Study Sees Economics Tumble

Gold Is Not Rising. Confidence Is Collapsing | Todd “Bubba” Horwitz

IAMGOLD: The Quebec Buying Spree

Recommended

First Majestic Silver Breaks Free Cash Flow Record In Third Quarter

Antimony Resources Sees Bald Hill Potential Double In Latest Technical Report

Related News

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Base Carbon Closes Reverse Takeover Deal, Looks At NEO Listing

Base Carbon Corp. announced on Friday the completion of the reverse takeover deal with 1287411...

Monday, February 28, 2022, 02:26:00 PM

Pet Valu Closes IPO Issuing 15.8 Million Shares, Raises $316.3 Million

Pet Valu Holdings Ltd. (TSX: PET) closed its initial public offering today, raising gross proceeds...

Wednesday, June 30, 2021, 11:39:00 AM

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the...

Tuesday, July 27, 2021, 10:47:00 AM

Tampa Bay Rays Owner-Led SPAC Counter Press Acquisition Prices US$75 Million IPO

Special purpose acquisition company Counter Press Acquisition Corp. (Nasdaq: CPAQU) started trading publicly on the...

Thursday, February 10, 2022, 02:21:00 PM